10 employees
Sepsia Therapeutics is developing new broad-spectrum drug and cellular therapies against sepsis.
1996
$82K
from 1 investors over 1 rounds
Sepsia Therapeutics raised $82K on January 1, 2019
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)